Skip to main content
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • Editorial Board
    • Meet the Editors
    • Editorial Manifesto
    • Impact Factor
    • Journal History
    • General Statistics
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Circulation Research Profiles
    • Trainees & Young Investigators
    • Research Around the World
    • News & Views
    • The NHLBI Page
    • Viewpoints
    • Compendia
    • Reviews
    • Recent Review Series
    • Profiles in Cardiovascular Science
    • Leaders in Cardiovascular Science
    • Commentaries on Cutting Edge Science
    • AHA/BCVS Scientific Statements
    • Abstract Supplements
    • Circulation Research Classics
    • In This Issue Archive
    • Anthology of Images
  • Resources
    • Online Submission/Peer Review
    • Why Submit to Circulation Research
    • Instructions for Authors
    • → Article Types
    • → Manuscript Preparation
    • → Submission Tips
    • → Journal Policies
    • Circulation Research Awards
    • Image Gallery
    • Council on Basic Cardiovascular Sciences
    • Customer Service & Ordering Info
    • International Users
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Impact Factor 13.965
  • Facebook
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Circulation Research

  • My alerts
  • Sign In
  • Join

  • Impact Factor 13.965
  • Facebook
  • Twitter
  • Home
  • About this Journal
    • Editorial Board
    • Meet the Editors
    • Editorial Manifesto
    • Impact Factor
    • Journal History
    • General Statistics
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Circulation Research Profiles
    • Trainees & Young Investigators
    • Research Around the World
    • News & Views
    • The NHLBI Page
    • Viewpoints
    • Compendia
    • Reviews
    • Recent Review Series
    • Profiles in Cardiovascular Science
    • Leaders in Cardiovascular Science
    • Commentaries on Cutting Edge Science
    • AHA/BCVS Scientific Statements
    • Abstract Supplements
    • Circulation Research Classics
    • In This Issue Archive
    • Anthology of Images
  • Resources
    • Online Submission/Peer Review
    • Why Submit to Circulation Research
    • Instructions for Authors
    • → Article Types
    • → Manuscript Preparation
    • → Submission Tips
    • → Journal Policies
    • Circulation Research Awards
    • Image Gallery
    • Council on Basic Cardiovascular Sciences
    • Customer Service & Ordering Info
    • International Users
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
Poster Abstract PresentationsSession Title: Poster Session 3

Abstract 334: An Inotropic S100A1-derived Peptide Enhances Contractile Performance and Survival of Post-ischemic Failing Hearts

Mauro Siragusa, Kristin Spaich, Mirko Völkers, Erhe Gao, Julia Ritterhoff, Hugo A Katus, Patrick Most
Circulation Research. 2015;117:A334
Mauro Siragusa
Dept of Internal Medicine III, Univ Hosp Heidelberg, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kristin Spaich
Städtisches Klinikum Karlsruhe, Karlsruhe, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mirko Völkers
Dept of Internal Medicine III, Univ Hosp Heidelberg, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erhe Gao
Cntr for Translational Medicine, Temple Univ Sch of Medicine, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julia Ritterhoff
Dept of Internal Medicine III, Univ Hosp Heidelberg, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hugo A Katus
Dept of Internal Medicine III, Univ Hosp Heidelberg, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick Most
Dept of Internal Medicine III, Univ Hosp Heidelberg, Heidelberg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics

Jump to

  • Article
  • Info & Metrics
  • eLetters
Loading

Abstract

S100A1 gene therapy was suggested as therapeutic for cardiomyopathies since myocardial levels of S100A1 are decreased in heart failure. S100A1 increases systolic and diastolic performance of cardiomyocytes through enhanced Ca2+-induced SR Ca2+ release and augmented SR Ca2+ re-uptake. These effects are due to enhanced systolic Type 2 Ryanodine Receptor (RyR2) and diastolic Sarcoplasmic/Endoplasmic Reticulum Calcium ATPase 2a (SERCA2a) activity. The S100A1 C-terminus (S100A1ct) was recently shown to be the bioactive domain of the protein. The aim of this study was therefore to characterize the effects of an S100A1ct-derived peptide on cardiomyocyte function and to test its therapeutic action in a mouse model of heart failure. An S100A1ct-derived peptide encompassing aa75-85 of the human S100A1 protein and preceded by a hydrophilic motif (DKDDPP) was named S100A1ct6/11. S100A1ct6/11 was cell permeable and accumulated in the intracellular space of intact rat ventricular cardiomyocytes in a striated pattern, similar to endogenous S100A1. S100A1ct6/11 exerted a time- and dose-dependent positive inotropic effect in electrical field stimulated rat ventricular cardiomyocytes. This effect was associated with the regulation of the SR calcium content. Peptides encompassing aa75-85 derived from S100 paralogs A4 and B did not mimic S100A1ct6/11-mediated inotropy. S100A1ct6/11 protected cardiomyocytes from pro-arrythmic store overload-induced calcium leak as well as from chronic caffeine exposure-induced apoptotic cell death. Mice intravenously injected with S100A1ct6/11 exhibited a significant enhancement of LV contractile performance under basal and βAR-stimulated conditions. Daily intraperitoneal administration of S100A1ct6/11 for two weeks to mice with post-ischemic contractile dysfunction resulted in significantly improved contractile performance and survival due to reduced myocardial apoptosis. Moreover, this treatment protected failing hearts with caffeine-induced leaky RyR2 channels from βAR-triggered lethal ventricular tachyarrhythmias. In conclusion, administration of the S100A1ct6/11 peptide may represent a novel option for the treatment of cardiomyopathies without apparent side effects.

  • Heart failure
  • Small molecule therapy
  • Inotropy
  • Author Disclosures: M. Siragusa: None. K. Spaich: None. M. Völkers: None. E. Gao: None. J. Ritterhoff: None. H.A. Katus: None. P. Most: 1. Employment; Significant; UniQure. 7. Ownership Interest; Significant; UniQure.

  • © 2015 by American Heart Association, Inc.
Back to top
Previous Article

This Issue

Circulation Research
July 17, 2015, Volume 117, Issue Suppl 1
  • Table of Contents
Previous Article

Jump to

  • Article
  • Info & Metrics

Article Tools

  • Citation Tools
    Abstract 334: An Inotropic S100A1-derived Peptide Enhances Contractile Performance and Survival of Post-ischemic Failing Hearts
    Mauro Siragusa, Kristin Spaich, Mirko Völkers, Erhe Gao, Julia Ritterhoff, Hugo A Katus and Patrick Most
    Circulation Research. 2015;117:A334, originally published October 21, 2015

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
  • Article Alerts
    Log in to Email Alerts with your email address.
  • Save to my folders

Share this Article

  • Email

    Thank you for your interest in spreading the word on Circulation Research.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Abstract 334: An Inotropic S100A1-derived Peptide Enhances Contractile Performance and Survival of Post-ischemic Failing Hearts
    (Your Name) has sent you a message from Circulation Research
    (Your Name) thought you would like to see the Circulation Research web site.
  • Share on Social Media
    Abstract 334: An Inotropic S100A1-derived Peptide Enhances Contractile Performance and Survival of Post-ischemic Failing Hearts
    Mauro Siragusa, Kristin Spaich, Mirko Völkers, Erhe Gao, Julia Ritterhoff, Hugo A Katus and Patrick Most
    Circulation Research. 2015;117:A334, originally published October 21, 2015
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Circulation Research

  • About Circulation Research
  • Editorial Board
  • Instructions for Authors
  • Abstract Supplements
  • AHA Statements and Guidelines
  • Permissions
  • Reprints
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Editorial Office Address:
3355 Keswick Rd
Main Bldg 103
Baltimore, MD 21211
CircRes@circresearch.org

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2018 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured